Plantamajoside inhibits hypoxia-induced migration and invasion of human cervical cancer cells through the NF-κB and PI3K/akt pathways

Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT/ GSK-3β signaling pathway

(2019) Linlin Shang et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes

(2019) Alexandru Andrei Tirpe et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Plantamajoside inhibits lipopolysaccharide-induced epithelial-mesenchymal transition through suppressing the NF-κB/IL-6 signaling in esophageal squamous cell carcinoma cells

(2018) Xiaohui Li et al.   BIOMEDICINE & PHARMACOTHERAPY

Nuclear factor 90 promotes angiogenesis by regulating HIF-1α/VEGF-A expression through the PI3K/Akt signaling pathway in human cervical cancer

(2018) Wenqian Zhang et al.   Cell Death & Disease

Epithelial-to-mesenchymal transition in cancer: complexity and opportunities

(2018) Yun Zhang et al.   Frontiers of Medicine

Plantamajoside attenuates inflammatory response in LPS-stimulated human gingival fibroblasts by inhibiting PI3K/AKT signaling pathway

(2018) Fei Liu et al.   MICROBIAL PATHOGENESIS

HIF-1α induces the epithelial-mesenchymal transition in gastric cancer stem cells through the Snail pathway

(2017) Shi-wei Yang et al.   Oncotarget

Dexmedetomidine protects against lung ischemia–reperfusion injury by the PI3K/Akt/HIF-1α signaling pathway

(2016) Wei Zhang et al.   Journal of Anesthesia

Hypoxia promotes the invasion and metastasis of laryngeal cancer cells via EMT

(2016) Jianhong Zuo et al.   MEDICAL ONCOLOGY

Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer

(2016) Bowen Du et al.   MOLECULES

Transcription Factor KLF2 in Dendritic Cells Downregulates Th2 Programming via the HIF-1α/Jagged2/Notch Axis

(2016) Ye Xiong et al.   mBio

Zinc finger protein 91 (ZFP91) activates HIF-1α via NF-κB/p65 to promote proliferation and tumorigenesis of colon cancer

(2016) Juan Ma et al.   Oncotarget

Hypoxia and metabolic adaptation of cancer cells

(2016) K L Eales et al.   Oncogenesis

Hypoxia, Epithelial-Mesenchymal Transition, and TET-Mediated Epigenetic Changes

(2016) Shih-Han Kao et al.   Journal of Clinical Medicine

Hypoxia-induced chemoresistance in cancer cells: The role of not only HIF-1

(2015) Helena Doktorova et al.   BIOMEDICAL PAPERS-OLOMOUC

Plantamajoside, a potential anti-tumor herbal medicine inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of matrix metalloproteinase-9 and -2

(2015) Shimin Pei et al.   BMC CANCER

HIF meets NF-κB signaling

(2014) Carsten Willam   KIDNEY INTERNATIONAL

Molecular mechanisms of epithelial–mesenchymal transition

(2014) Samy Lamouille et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Aberrant Expression of Hypoxia-inducible Factor 1 , TWIST and E-cadherin is Associated with Aggressive Tumor Phenotypes in Endometrioid Endometrial Carcinoma

(2013) Z. Feng et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Tumour Hypoxia Affects the Responsiveness of Cancer Cells to Chemotherapy and Promotes Cancer Progression

(2012) Jean-Philippe Cosse et al.   Anti-Cancer Agents in Medicinal Chemistry

Expression of the E-cadherin repressors Snail, Slug and Zeb1 in urothelial carcinoma of the urinary bladder: relation to stromal fibroblast activation and invasive behaviour of carcinoma cells

(2012) Julia Schulte et al.   HISTOCHEMISTRY AND CELL BIOLOGY

Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells

(2011) Christina D. Befani et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

TWIST activation by hypoxia inducible factor-1 (HIF-1): Implications in metastasis and development

(2010) Muh-Hwa Yang et al.   CELL CYCLE

NF-κB mediates aberrant activation of HIF-1 in malignant lymphoma

(2010) Qiao Qiao et al.   EXPERIMENTAL HEMATOLOGY

The NF-κB activation pathways, emerging molecular targets for cancer prevention and therapy

(2009) Yong Lin et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Characterization of LMX-1A as a metastasis suppressor in cervical cancer

(2009) Chin-Yu Liu et al.   JOURNAL OF PATHOLOGY

Changes in the expression of E-cadherin repressors, Snail, Slug, SIP1, and Twist, in the development and progression of ovarian carcinoma: the important role of Snail in ovarian tumorigenesis and progression

(2009) Junko Yoshida et al.   Medical Molecular Morphology

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

(2009) G L Semenza   ONCOGENE